We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Top Buys

Rank Stock Value
1
FALN icon
iShares Fallen Angels USD Bond ETF
FALN
+$9.31M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$6.87M
3
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$3.6M
4
CORT icon
Corcept Therapeutics
CORT
+$3M
5
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$2.68M

Top Sells

Rank Stock Value
1
ESGV icon
Vanguard ESG US Stock ETF
ESGV
+$9.63M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$7.01M
3
MSFT icon
Microsoft
MSFT
+$5.41M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$5.16M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.44M

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
3001
Cullinan Oncology
CGEM
$1.14B
$0 ﹤0.01%
+6
New +$81
CGNT icon
3002
Cognyte Software
CGNT
$680M
$0 ﹤0.01%
+18
New +$208
CHRS icon
3003
Coherus Oncology
CHRS
$196M
– –
-6
Closed –
CIFR icon
3004
Cipher Digital
CIFR
$7.13B
– –
-20
Closed –
CIM
3005
Chimera Investment
CIM
$1B
$0 ﹤0.01%
10
+1
+11% +$40
CIVI
3006
DELISTED
Civitas Resources
CIVI
$0 ﹤0.01%
2
-43
-96% -$2.34K
CLW icon
3007
Clearwater Paper
CLW
$376M
– –
-500
Closed -$18K
CMTL icon
3008
Comtech Telecommunications
CMTL
$51.8M
$0 ﹤0.01%
24
– –
CNOB icon
3009
Center Bancorp
CNOB
$1.78B
$0 ﹤0.01%
+12
New +$401
CNXN icon
3010
PC Connection
CNXN
$2.12B
$0 ﹤0.01%
3
-51
-94% -$2.41K
COHU icon
3011
Cohu
COHU
$2.5B
$0 ﹤0.01%
16
+5
+45% +$160
COLL icon
3012
Collegium Pharmaceutical
COLL
$956M
– –
-15
Closed –
CPA icon
3013
Copa Holdings
CPA
$5.8B
$0 ﹤0.01%
3
-276
-99% -$22.7K
CPS icon
3014
Cooper-Standard Automotive
CPS
$558M
$0 ﹤0.01%
30
-46
-61% -$752
CRS icon
3015
Carpenter Technology
CRS
$28.4B
$0 ﹤0.01%
4
-32
-89% -$1.12K
CRVS icon
3016
Corvus Pharmaceuticals
CRVS
$1.17B
$0 ﹤0.01%
20
– –
CSR
3017
Centerspace
CSR
$952M
– –
-17
Closed -$2K
CTO
3018
CTO Realty Growth
CTO
$815M
$0 ﹤0.01%
15
-78
-84% -$1.61K
CTRE icon
3019
CareTrust REIT
CTRE
$9.74B
$0 ﹤0.01%
+11
New +$217
CTRN icon
3020
Citi Trends
CTRN
$605M
$0 ﹤0.01%
9
– –
CTSO icon
3021
Cytosorbents Corp
CTSO
$22.6M
– –
-226
Closed -$1K
CURI icon
3022
CuriosityStream
CURI
$161M
– –
-8
Closed –
CWK icon
3023
Cushman & Wakefield Ltd
CWK
$3.25B
$0 ﹤0.01%
11
-200
-95% -$4.24K
CYTK icon
3024
Cytokinetics
CYTK
$10.4B
$0 ﹤0.01%
+7
New +$249
DADA
3025
DELISTED
Dada Nexus
DADA
$0 ﹤0.01%
25
-10
-29% -$97
119 120
121
122 123

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.